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Introduction
In 2015, the number of maternal and fetal deaths is still too high. In particular, the
65% of maternal deaths is associated to problems related to Non-Communicable
Diseases (NCDs) during pregnancy. Over 75% of these deaths are in underdevel-
oped and developing countries. Most of these deaths may have been prevented.
Generally speaking, pregnancy, in women with NCDs, implies the emerging of
high-risk pregnancy. The best way to avoid serious complications is to improve
maternal health before, during and after pregnancy.
Access to health-care facilities should be guaranteed to all women in order to
achieve continuous monitoring of pregnancy progress. This leads to promptly
complications detection and, consequently, in taking corrective actions and/or ini-
tiating recommended prophylaxis.
Information Technology plays a key role in this context. Mobile Health (M-Health)
is the general term used to indicate medical support provided by mobile devices.
M-Health helps the monitoring process providing support for both physicians and
patients. It represents a way to facilitate access to health-care services transcend-
ing time and space providing support to everyone, everywhere and anytime.
In environment permeated by sensors it is possible to collect information about
the patient and his context. Such information, while correctly elaborated, de-
scribe potentially any kind of situations like real-world ones. In order to describe
or predict events, data from environment could be elaborated by different analysis
techniques, from statistics and mathematics to Artificial Intelligence algorithms.
These techniques may be exploited to describe a system through the patterns dis-
cover or predict the future values of specific systems attributes on the basis of
other ones.
Among several studied approaches, the one that we choose is simulation. In par-
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ticular we paid attention on Multi Agent-Based Modeling and Simulation (MABS)
approach. Such kind of approaches is particularly related to complex systems be-
cause of nature: an agent is thought of as an autonomous entity with a behavior
that interact with other agents creating real societies. Such behavior is described
by rules. Based on their behavior, agents may be reactive or proactive entities.
A reactive behavior describes how the agent has to react to external stimuli, a
proactive behavior describes how it behaves in order to perform its goals. Agents
may be capable to evolve by adapting to changing environment.
The main advantage of using simulation techniques is the capability of reproduc-
ing evolution of the system under controlled conditions. In this way is possible
to understand which factors influence more the evolution of the system. These
factors are usually difficult to evaluate in many real-world situations, one of them
being the description of physiological processes in humans.
Considering the importance of factors influencing pregnancies, this thesis has as its
goal the modeling of high-risk pregnancy condition starting from model described
in [2]. Among the several pregnancy complications, we focused on the Gestational
Diabetes Mellitus one.
This thesis is structured as follow:
• In the first chapter we will explore literature about the maternal and fetal
mortality problem. The focus will be on main problems arising from preg-
nancy complications and which factors are connected to it. Among these risk
factors particular attention will be paid for Non-Communicable Diseases and
their influence on pregnancy outcome. Current challenges aim to improve
maternal and fetal health will be shown in the later sections. Finally we will
show the case of Emilia Romagna considering the data collected through
CedAP, highlighting the statistics that emerged in this year with regards to
pre-term births examinations and obesity complications.
• In the second chapter we will explore literature about the use of technology
in health-care area. In particular we will give an overview about terminology
and its technological influence in medicine. Particular importance will be
given to Mobile Health-care systems. We will describe ICT applications in
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health-care area and benefits and drawbacks arising from them. Finally we
will describe current challenges affecting this area and the vision of Hospital
4.0.
• In the third chapter we will explore ICT applications in the specific field of
pregnancy monitoring. We will describe which systems are used to support
pregnant women achieving a healthy pregnancy. We will show the architec-
ture of M-Health systems with particular attention given to data processing
techniques such as Machine Learning and Simulation Techniques. Finally
we will describe Agent-Based modeling and simulation approach showing
characteristics of such systems.
• In the fourth chapter we will provide a physiological description to Ges-
tational Diabetes Mellitus model. In particular we will describe glucose
metabolism and the physiology of main organs involved in it. We will de-
scribe metabolic changes arising from pregnancy and its influence on metabolism.
At the end of chapter we will introduce the Self-Management system model
used to simulate a healthy and Type-1 diabetic patient metabolism.
• In the fifth chapter we will introduce case study of current Type-1 diabetes
self-management system model. Before that, we will explain the experience
about the initial decision to using machine learning techniques in order to
predict future outcome of high-risk pregnancy. We will explain the changes
made on the aforementioned system in order to simulate healthy pregnancy
and Gestational Diabetes Mellitus complicated pregnancy. In particular,
which improvements have been made on existing model and the addition of
the placenta one to the system. We will show the changes introduced by the
new organ on metabolism of the other ones. Results of simulation will be
shown at the end of chapter.
• At the end of this thesis we will provide conclusions containing considerations
about the actual systems and possible future works on it.
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Chapter 1
Background
This chapter describes the background on maternal and fetal mortality world prob-
lem.
In particular we initially describe in details the problem of fetal mortality and
morbidity and resulting consequences.
A great deal of attention is paid to describe the causes of this problem and which
disorders are connected to it. About risk factors, particular attention is paid on
Non-Communicable Diseases (NCDs) such as obesity, hyperglycaemia and hyper-
tension. At the end of this section we present the results of recent studies related
to it.
Later we describe current challenges to accept in order to improve maternal and
fetal health.
Finally we show the specific case of Emilia Romagna considering the data collected
through CedAP, highlighting the statistics that emerged during this year with re-
gards to examinations in pregnancy, pre-term births and obesity complications.
1.1 The Problem
Over the past two decades, improving maternal health has became an increasingly
important focus of the global development agenda [3]. Many pregnancies are lost
during early gestation. Some studies report percentages of fetal loss in more than
50% of pregnancies [4].
1
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At the moment European Commission is so much interested to improve health-
care systems, so they organize a call for paper about ”Implementation research for
maternal and child health” topic [5].
Fetal mortality is closely related to maternal mortality, which is defined by the
World Health Organization (WHO) as the death of a woman while pregnant or
within 42 days of termination of pregnancy, irrespective of the duration and site
of the pregnancy, from any cause related to or aggravated by the pregnancy or its
management but not from accidental or incidental causes.
Even though between 1990 and 2015 maternal mortality worldwide dropped by
about 44%, it remains unacceptably high: the WHO assesses that in 2015 about
303 000 women died during pregnancy and follow childbirth, and roughly 2.6 mil-
lion of babies were stillbirth. It’s important to note that most of these deaths
could have been prevented.
The high number of deaths in low-resource countries reflects inequities in access to
health services. The Maternal Mortality Ratio - MMR (the number of maternal
deaths per 100’000 live births) in developing countries is 14 times higher than in
developed countries ones [6].
”Ensure healthy lives and promote well-being for all at all ages” is the third of
17 Sustainable Development Goals (SDGs) for 2030 and it aims to reduce global
MMR to less than 70 deaths per 100’000 live births. Achieving this global target
requires a global annual maternal mortality rate reduction of at least 7.5%, more
than double of the rate achieved between 2000 and 2015 [7].
The main cause of maternal and fetal mortality in underdeveloped and developing
countries is access to care. There are no roads, transportation and health facilities
in countries such as Burundi and Cameroon, in sub-Saharan Africa.
The low level of education, weak health systems, lack of skilled birth attendants
and no capacity to deliver essential life-saving interventions helps make it difficult
to receive the necessary medical care [8].
Non-Communicable Diseases (NCDs) such as diabetes, obesity and hypertensive
disorders are strongly connected with maternal health. They have a significant ad-
verse impact on pregnancy outcome and child health, as well as maternal health.
Parents health, in particular metabolic and nutritional state of the mother during
pregnancy, defines the environment in which the fetus grows. This environment
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may lead to increased risk of developing NCDs later in life [9]. There are hy-
potheses regarding the predisposition to non-communicable diseases developed in
adulthood. This would be the result of exposure to certain intrauterine conditions
that influence the development of important tissues during critical stage of preg-
nancy.
Worldwide NCDs are responsible for about 65% of maternal deaths. Over 75%
of these deaths are in underdeveloped and developing countries [10]. Diabetes,
anaemia, hypertensive and thyroid disorders are also associated with preterm birth
(also known as premature birth), that is the birth of a baby at fewer than 37th
weeks gestational age.
NCDs such as denutrition, obesity, hypertension and hyperglycaemia are com-
monly associated with pregnancy as causes of maternal morbidity and mortality.
Figure 1.1: Global estimates of common NCDs affecting pregnancy [9]
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1.2 Causes
Several studies show that countless factors contribute to determine the outcome
of pregnancy. Many of them are strongly related with the socio-economic envi-
ronment in which women live, such as lack of basic infrastructures, communicable
diseases and undernutrition.
These factors will not be studied in deep in this work.
1.2.1 Risk factors
Maternal Nutrition Worldwide almost 870 million people suffer from chronic
malnutrition, 60% of these are women and girls. Undernutrition affects the out-
come of pregnancy because it can determine low birth weight (LBW) and subse-
quent childhood malnutrition and it contributes significantly to maternal morbidity
and mortality and neonatal mortality.
Nutritional iron deficiency in maternal diet can lead to anaemia development, de-
fined as haemoglobin concentration (Hb) < 110 g/L. In most cases it is associated
with increment of maternal and perinatal morbidity and mortality and long-term
adverse consequences involving the baby.
Women with serious forms of anemia have an higher risk to develop pre-eclampsia,
with consequent onset of eclampsia, in comparison to non-anaemic women. In
medical application eclampsia is defined as the direct and worst complication of
pre-eclampsia, with onset of seizures (convulsions). Pre-eclampsia, in turn, is a
pregnancy disorder characterized by the onset of edema (abnormal fluid accumu-
lation in the interstitium, located under the skin, in the cavities of the body),
hypertension (high blood pressure) and often proteinuria (significant amount of
proteins in the urine).
The most serious cases of anaemia are associated with pre-term births, low birth
weight (LBW) defined by the WHO as a birth weight of an infant of 2,499 g or
less regardless of gestational age, and perinatal death.
Another factor linked to maternal nutrition is vitamin B12 deficiency. This de-
ficiency in pregnancy causes on one hand an high risk of insuline resistance with
consequent development of type 2 diabetes, on the other an increased incidence of
4
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Gestational Diabetes Mellitus (GDM) [9].
Non-Communicable Diseases
Increase of Impaired Glucose Tolerance (IGT), diabetes and other NCDs in de-
veloping countries is not to be only attributed to genetic risk factors and onset
of obesity. In low and middle-incoming countries individuals who are affected by
such diseases are, in most cases, not obese.
The concept of ”fetal programming” is related to predisposition to multiple NCDs
and it is defined as ”a permanent structural or physiological function change in
utero during development of organs as a result of defined stimulus. This change
depends on type and timing of exposure”. When a malnourished mother’s child
introduces calories with diet in his/her early childhood, he/she develops anthro-
pometric and biochemical markers of metabolic syndrome and consequently an
high risk for developing diseases like IGT, diabetes, arterial hypertension, coro-
nary heart diseases, lipid abnormalities and stroke later in life [11].
This concept leads to argue that the origin of Non-Communicable Diseases is to
attribute not only to genetic factors, but also to many environmental ones acting
early in life. These can lead to ”developmental mismatch” defined as ”mismatch
occurring between generation and within the life-course of the individual if the en-
vironment in which they live changes” [12].
According to this model, components that critically influence the risk of NCDs
has been established during early gestation. In this period informations about the
current environment affect both tissues formation and settings process responsible
of individual reactions based on changes of surrounding environment.
Such informations are handed down by the mother during pregnancy and nursing
of the infant. This process is influenced by many factors such as mother’s ge-
netic makeup, her nutritional state, lifestyle, parity and external stressors. This
mismatch between information biologically handed down and environment that
evolves over time suggests an increased risk of developing NCDs, such as obesity
and diabetes in the next generation.
NCDs during pregnancy increase the risk of miscarriage, stillbirth, congenital mal-
formations, birth injuries, neonatal hypoglicaemia, infant respiratory distress syn-
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drome and being Large for Gestational Age (LGA) which implies having weight
that is above the 90th percentile for that gestational age [10].
Factors such as unhealthy diet, physical inactivity, tobacco use and abuse of alcohol
contribute to the increase risk of developing NCDs.
Obesity Obese individuals are those who have a Body Mass Index (BMI) greater
than 30 kg/m2, those who have BMI between 25 and 30 kg/m2 are overweight.
Obesity and overweight are among the main risk factors of fetal mortality in high-
income countries. The number of reproductive-aged women who are obese and
overweight is growing.
Maternal obesity is linked to an increased risk of obesity in the offspring [12],
birth complications such as induction of labour, caesarean section (C-section),
post-partum haemorrhage, maternal infections and shoulder dystocia, and onset
of pre-eclampsia, thrombosis and GDM. The pre-eclampsia risk grows as BMI
increases [9].
A serious problem concerning overweight and obesity is the risk of Intrauterine
Growth Restriction (IUGR) defined as poor fetal growth in the mother’s womb.
Hyperglycaemia Hyperglycemia is a condition in which an excessive amount
of glucose circulates in blood plasma. This condition arises in those who have
diabetes.
At the moment, diabetes is a critical aspect of maternal health. 92% of diabetic
women are in low and middle-income countries, where they have a limited access
to health-care facilities. Health systems are often not structured and poorly orga-
nized to provide them appropriate cares [13].
Chronic medical condition such as diabetes may greatly affect the course of preg-
nancy because the high maternal glucose concentration crosses placenta and, with
the normal levels of fetal insulin, allows a growth above average of the fetus. Dia-
betic women’s babies are thus often large for gestational age.
Almost 90% of all cases of diabetes during pregnancy are gestational diabetes
[11].
Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance of variable
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severity with onset or first recognition during pregnancy. Worldwide, between 2
to 9% of all pregnancies are affected by GDM. This kind of diabetes is associated
with fetal macrosomia and perinatal risks such as shoulder dystocia, bone frac-
tures, nerve palsies and hypoglycaemia [14].
Babies born from a mother with Gestational Diabetes Mellitus risk to developing
several complications including perinatal death. Other delivery problems, includ-
ing haemorrhage, obstructed labour, infection and sepsis, hypertensive disorders
and cardiovascular diseases (CVD) are directly or indirectly connected to GDM
and leading causes of maternal mortality. Women which have been already diag-
nosed type-1 or 2 diabetes have the same risks and, beyond these, the problems
linked to diabetes may get worse with the pregnancy [10]. Women with GDM
and their offspring have an increased risk of developing type-2 diabetes, impaired
glucose tolerance (IGT) and obesity later in life [13]: between 30% and 70% of
women with GDM will develop type-2 diabetes and an increased risk of cardiovas-
cular diseases [11].
Hypertension Hypertension is the widespread problem seen during pregnancy.
This disorder complicates almost 10% of pregnancies. Hypertensive pregnancy
disorders (HPD) are responsible for 10% of maternal deaths in underdeveloped
and developing countries and they are the major contributors to prematurity [9].
Diabetes, low metabolic control and pregestational microalbuminuria or high blood
pressure increase the risk of pre-eclampsia in gestational diabetic women [15].
HPDs are commonly classified as: gestational hypertension or pregnancy-induced
hypertension that is hypertension without proteinuria; pre-eclampsia, hyperten-
sion with proteinuria; chronic hypertension or essential hypertension that is pre-
existing hypertension; chronic hypertension with superimposed pre-eclampsia.
Pre-eclampsia and eclampsia may lead to an increased risk of renal/liver failure,
clotting disorders, stroke, premature birth (that includes stillbirth and neonatal
death) and C-section or emergency C-section. Women with previous hyperten-
sive disorders potentially have risk of high glucose, insulin, triglycerides and total
cholesterol concentration in blood after pregnancy.
HPD is associated with cardiovascular and metabolic disorders, including hyper-
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tension, type-2 diabetes and dyslipidaemia (abnormal amount of lipids in the
blood). Both, mother and offspring could have long-term consequences deriv-
ing from HPD [9].
1.2.2 Results
Improving maternal health implies decreasing fetal deaths, even if it is not always
possible.
The study of maternal death cases is often not possible because of vital registra-
tion systems lack in most countries and inadequacy of databases. It is also true
that informations about many causes of death are often subject to errors such as
misclassification and misinterpretation of the incident or omissions because of the
particular treated problem. Information data is also often incomplete.
Sometimes it is also difficult determine whether a pregnancy might be an high-risk
pregnancy as result of aggravation of pre-existing medical disorders. Recording
the correct sequence of events is essential [16].
In order to prevent NCDs, understanding the role of maternal hyperglycaemia and
obesity is essential. Numerous studies do point out the association between mater-
nal hyperglycaemia and child obesity [12]. It emphasizes how important maternal
health is.
Pre-gestational and gestational diabetes may already be the leading cause of high-
risk pregnancies in many countries. Fetal effects are dependent on duration and
exposure to high blood glucose level [11].
The fetal environment is represented by mother health status, which determines if
newborn will start his/her life with a health ”advantage” or ”handicap”. Exactly
this can determine whether someone is more vulnerable to disease development
than those who are born with ”health advantage” [9].
Preterm birth is closely connected to newborn long-term neurological disabilities
and infant death. Priority is given to chronic diseases such as diabetes, hyperten-
sion, asthma and renal disease as risk factors of preterm births [17].
Other studies show that multple factors can predict possible miscarriage during
first trimester. Among various factors involved, a strong correlation between high
8
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maternal age, low BMI, high concentration of Corticotrophin-Releasing Hormone
(CRH), low level of Progesterone-Induced Blocking Factor (PIBF) and fetal loss
has been found [4].
Low BMI of the mother (less than 20 kg/m2) proved to be a risk for miscarriage
during first trimester of gestation (4-7 weeks) regardless of mother’s age. Inter-
esting to note is the association between progesterone and woman’s age with no
relation to gestational age. Low progesterone concentration (12 ng/ml) is linked
to an increased risk of miscarriage in older women (more than 33 years old) for
the duration of first trimester.
Early miscarriage would also be caused by high levels of cortisol, which is detected
with an increased of stress perception.
Anterior pituitary gland releases CRH to regulate cortisol secretion, but placenta
produces cortisol too. Adverse effects on uterus and fetus are registered by high
levels of glucocorticoids that inhibit pituitary luteinizing hormone, ovarion estro-
gen and progesterone secretion. This could result in miscarriage. Pharmacological
intervention is essential to keep the right concentration of progesterone, and it
must be done as soon as the risk of miscarriage is suspected [4].
The risk of spontaneous abortion increases if some factors occur together.
The International Diabetes Federation’s Diabetes Atlas estimates that about 76
million women in reproducible age suffer from diabetes or impaired glucose to-
lerance\pre-diabetes. This means that their pregnancies will be potentially af-
fected by diabetes. This creates a ”vicious cycle of diabetes begetting diabetes”
[18].
The [13] study show that the most frequent pregnancy outcomes of women with
GDM were C-section, macrosomia, stillbirth and newborn jaundice.
Several studies show that multiple kinds of phisical activities are associated with
a lower risk of developing type-2 diabetes and a better management of this disease
[19].
Treatment of GDM in the form of dietary advices, blood glucose monitoring and
insulin therapy with an adjusted dose on the basis of glucose levels limits the onset
of bone fracture, nerve palsy, shoulder dystocia and death without increasing the
rate of c-section [14].
Diet plays an essential role in the treatment of GDM. As a 2017 study suggests,
9
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rich feeding of probiotic, fruits and vegetables may protect against GDM with their
antioxidant properties and micronutrients (such as magnesium and vitamin C). At
the moment, adhere to Mediterranean diet could be the best way to prevent GDM
[20].
Women with undiagnosed and uncontrolled gestational diabetes expose fetus to
high levels of glucose and other circulating fuels that during the late part of preg-
nancy result in a large baby [11].
An increment of maternal and perinatal morbidity and mortality is relating to
undiagnosed or mismanaged diabetes or hyperglycaemia during pregnancy. Hy-
perglicaemia and hypertensive disorders are clear indicators of possible high future
risk for hypertension and diabetes that can be used to prevent serious complica-
tions such as adverse pregnancy outcome such as miscarriage, stillbirth, congenital
anomalies, macrosomia and birth complication (including C-section and assisted
delivery) [18].
1.3 Challenges
The imperative is improving maternal health-care through appropriate health fa-
cilities and basic infrastructures in low and middle-income countries.
First objective of [21] is, according to SDGs, ”survive” with the meaning of end-
ing preventable deaths within 2030. In order to achieve this goal it provides a
roadmap. Firstly, research is essential to understand and overcome the barriers
to health services for women and their children. Innovation is the beginning of
transformation of powerful new ideas and scientific evidences into widely used in-
terventions. Research can also leads to stronger systems and to improved service
quality, efficiency and effectiveness. Data acquisition (such us monitoring) must
be done in exhaustive and accurate way to improve accuracy of tools and infor-
mation.
Dr. Babatunde Osotimehin, Executive Director from United Nations Population
Fund in order to achieve goal 3 of SDGs, says that good nutritional advices are
important to have a balanced diet with micronutrients (diet should be rich in fruit
and vegetables) as well as comprehension of the body and access to health services
is essential to prevent a wide range of diseases [22].
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Considering the importance of in-depth analysis on causes of maternal death, reg-
istering good informations about that is essential: distinguishing between aggra-
vation of pre-existing diseases and external actions, for example, is important to
attribute the maternal death to the correct causes. Documentation of correct and
accurate sequence of events needs to be improved [16].
Chronic disease managements is important to avoid pre-term births. Understand-
ing complications that have occurred in previous adverse pregnancies it is the best
way to handle upcoming pregnancies at best. Identifying high-risk pregnancies de-
pends, among other things, on treatment options available to women. Improving
the health-care systems is necessary to reduce poor birth outcomes [17].
Understanding every facet of how diabetes in pregnancy affects maternal and new-
born health is important to promote cooperation among interventions to treat this
disease. Intervention like screening for diabetes as a standard care for pregnant
women, getting nutrition advices and taking physical activity could be the first
step to improve future generation health [3].
Appropriate dietary modification and physical activity can be enough to control
gestational diabetes. Choosing to use a better treatment such as close monitoring
makes possible to achieve optimum metabolic control to normalize blood sugar
level [11].
Estimates have shown that early detection and management of diabetes in preg-
nancy could help to reduce stillbirth up to 45% and maternal and newborn death
too [10].
An integrated approach to maternal health and NCDs could provide benefits to
both, considering the known enhanced risk of maternal and perinatal mortality
and morbidity. The stress is on benefits for NCDs prevention rather than cure.
Women with pre-existing diabetes have to access to preconception counseling for
reducing risks for them and their offspring. These informations need to be inte-
grated by supportive policies and suitable programs, that can have on one hand
immediate effect on pregnancy outcome, and on the other long-term benefits to
mother and future generation [10]. This initiative could have significant positive
effects on the overall health of the family and community.
Pregnancy offers a ”window of opportunity” that allows to provide maternal care
services for prevention of several chronic diseases through generations.
11
CHAPTER 1. BACKGROUND
1.4 The Case of Emilia Romagna
The CedAP (Certificato di Assistenza al Parto, that is childbirth certificate) pro-
vides health, epidemiological and socio-demographic information about births,
stillbirths and new-born babies suffering by malformations. These data are impor-
tant for public health and necessary for national and regional health planning.
The [23] is the result of CedAP certificates processing and contains data coming
from hospital discharge cards about 34.155 births, related to 34.790 babies oc-
curred in Emilia Romagna.
1.4.1 Examinations in Pregnancy
This report shows, inter alia, that, average number of examinations in pregnancy
is 6,7. 3,8% of women carries out less than 4 medical visits (or no-one) and 10,8%
of women have first examination over 12 weeks of gestation (women with a low
or medium level of education are more likely to perform their first visit later than
women with high education) and these indicators are worsening in the last year.
For women who have late access to the first check during pregnancy the probability
of making a lower total number of visits is higher. To identify possible high-risk
pregnancies, multiple and timely examinations are essential.
The number of ultrasounds performed during pregnancy is on average 4.8, but it
could be overestimated because it’s still impossible distinguish between ultrasound
screening for diagnostic purposes (formal ultrasound) and ultrasound to complete
the visit.
According to data, women that carry out invasive prenatal investigations are de-
creasing, while those who decide to undergo the combined test (non-invasive) are
increasing.
It seems that 17,4% of pregnancies have a pathological course and the remaining
have physiological course.
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1.4.2 Pre-Term Births
The [23] shows that pre-term births (less than 37 weeks of gestation) in Emilia
Romagna are the 6,8% excluding c-section without labour, while delivery is induced
in 26.7% of cases, and this data is increasing. Premature rupture of membranes
(occurred in 30.0% of cases), maternal pathology (27.9%) and prolonged pregnancy
(22.3%) are the most frequent reasons.
Pre-term births seem to be more frequently in:
- multiple pregnancies (57,4%) than the single ones,
- primiparous women compared to multiparous (7,5% vs 6,0%),
- women with low education (7.2% vs 5.9% of women whit high schooling)
- women with foreign citizenship (7.3% vs 6.5%),
- obese women (8.0% vs 6.5% of women with regular BMI).
Children born pre-term have a chance to get CPR (cardiopulmonary resuscitation)
almost 8,5 times more than those born at gestational age over 37 weeks.
Women with low education have greater risk of serious SGA babies compared to
those who have a university degree.
1.4.3 Obesity Complications
Obesity is universally recognized as a risk factor towards pregnancies. Emilia Ro-
magna, where the population is suffering an increase in its impact as a factor of
pre-gravidational BMI, confirms this claim too.
The audit revealed that in overweight/obese women stillbirth is strongly associated
with hypertension, and almost half of these women have weight increase exceed-
ing the recommended maximum limits. This fact exasperates cardiovascular and
metabolic disorders.
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Chapter 2
ICT for Health-Care
This chapter describes the use of telecommunication technology in health-care
area.
In particular we give an overview about terminology used in this area, describ-
ing concepts like Health Information Technology, E-Health, Electionic Health
Record, Health Informatics, telemedicine, telehealth and the differences between
telemedicine and e-health. Particular importance shall be given to mobile and
pervasive health-care.
We review applications of ICT in health-care, highlighting their benefits and draw-
backs.
We finally describes current challenges affecting this area and the vision of Hospital
4.0.
2.1 Technological Influence in Medicine
Technology today pervades every single aspect of modern society. Telecommu-
nication technologies have changed and influenced the entire structure and orga-
nization of the medical environment in unpredicted and irreversible way. These
technologies allow to provide treatment to patients away from health facilities and
simplify the exchange of information between all the parties involved (patients and
physicians)[24].
Over time many terms are born for defining and describing every aspect of this
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area and this fact does not make it easy to understand what does each of these
terms mean. The following subsection is useful to clarify these concepts.
2.1.1 Disambiguation
According to [25], Health Information Technology (HIT) is defined as ”the ap-
plication of information processing involving both computer hardware and software
that deals with the storage, retrieval, sharing, and use of health-care information,
data, and knowledge for communication and decision making”. In this case, tech-
nology includes machines that can be networked to allow secure health information
exchange.
E-Health, acronym of Electronic Health, is a term born in 1999 and it refers to
health-care delivery through Internet. Several authors give different definitions of
the term, but it can be considered as an ”umbrella term” needed to describe the
use of information and communication technology in health-care area [24].
Among many definitions, the most significant one we think could be the following:
”E-Health is a field rising halfway between medical informatics, public health and
business. This field concerns health services and information provided through
the Internet and related technologies. In a broader sense, the term characterizes
not only a technical development, but also a state-of-mind, a way of thinking, an
attitude, and a commitment for networked, global thinking, to improve health-
care locally, regionally, and worldwide by using information and communication
technology” [26]. The goal of E-Health is increasing the efficiency of health-care,
exploiting a mean (Internet) that allows to do what previously was impossible [24].
E-Health includes component of health information technology such as Electronic
Health Record (EHR), Health Information System, Telemedicine, M-Health, and
others.
Electronic Health Record, previously known as Electronic Medical Record
(EMR), is the systematic collection of patient and population informations stored
on electronic media. The correct definition of these term is controversial. While on
one hand EHR is a transversal collection of electronic health informations about
patient and population, on the other EMR is born to store health information
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about patients within health-care facility and for specific use of medical staff.
EHR draws on EMR information.
EHRs are networked to allow information exchange and captures the state of pa-
tients across time. The EHR system is basically a repository of health digital
informations of patients [27].
Health Informatics, also known as Health Information System, understood as
the systematic application of HIT to improve health-care, is defined by United
States National Library of Medicine (NLM), the world’s largest medical library,
as ”the interdisciplinary study of the design, development, adoption and appli-
cation of IT-based innovations in health-care services delivery, management and
planning” [28] and it includes several discipline such as computer science, social
science, and management science, in order to reduce costs and increase availability,
optimizing the management and use of informations.
Telemedicine is the use of telecommunication and information technology to
provide health-care services, clinical information, and education over distance. In
many cases, no physician is involved and interactivity is not necessary [24].
These technologies allow communications between patient and medical staff in a
safe and convenient way.
The WHO defines telehealth as ”the integration of telecommunication systems
into the practice of protecting and promoting health, while telemedicine is the
incorporation of these systems into curative medicine” [24]; this practice includes
preventative and curative care delivery such as non-clinical applications like ad-
ministration and provider education.
Telehealth and telemedicine are considered by The American Telemedicine As-
sociation synonyms [29], but generally it is commonly referred to telehealth as
something used more broadly for remote health not involving active clinical cares.
2.1.2 Comparison between E-Health, Telemedicine and Tele-
health
With the advent of Internet, the birth of E-Health should be not understood as a re-
placement of telemedicine and telehealth, but rather as a complement. Now health-
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care is not just accessible, it can be radically changed [24]. The first and, maybe,
most important difference between E-Health and telehealth and telemedicine is
not being for professionals uses only [24]: e-health is driven by non-professionals,
while telemedicine and telehealth remains connected to medical professionals [30].
There are many E-Health services that lead to a possible financial gain, whereas
it is not the case for telemedicine and telehealth [24].
E-Health can be introduced as ”the death of telemedicine” because in a context
where medical systems have to communicate, telemedicine will no longer exist as
a traditional medical informatics field. E-Health is a common name for all such
technological fields [30].
According to professor Vincenzo Della Mea, the meaning of E-Health is proper-
ties, possibilities and consequences of integrated-health-care-systems that are (in
a holistic approach) more than the sum of the single-component outcomes [30].
2.1.3 Mobile Health
In 2011, the mobile technology penetration rate was the 87% worldwide. In de-
veloping countries it surpassed infrastructures like paved roads, electricity and
running water [31]. As reported in [32], by end 2015, there are more than 7 billion
mobile phone subscriptions, corresponding to a penetration rate of 97% . Diffu-
sion, convenience and practicality of use make mobile devices suitable platforms for
accessing, managing and providing health-care services. M-Health (Mobile Health)
is defined as the health-care supported by networked mobile devices and mobile
communications [33].
This emerging concept can be considered as an aspect of E-Health and it marks
the passage from telemedicine that worked through use of traditional platforms to
health-care passing through mobile device such as mobile phone, tablet comput-
ers, PDAs (Personal Digital Assistant) and wearable devices for health services,
information and data collection [33].
Aspect of fundamental importance in m-health is communication between devices
that must be always reliable, interactive and available to improve the administra-
tion of health-care services [31].
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Pervasive health-care is the environment in which M-Health is located, which in-
cludes a wide scale deployment of wireless networks; as a result, health-care services
are delivered anytime and anywhere, with a reduction of medical errors and an
improvement of information access.
Pervasive health-care systems contains everyday objects equipped with sensors
and memory which make them capable of collecting data from environment, ex-
changing information each other and reacting on the basis of constraints previously
defined [34].
Another fundamental aspect of pervasive health-care is the concept of ”wearable
computing”. Computers that become part of everyday clothing always connected
to devices that assist users in everyday situations [34].
Social networks are changing the everyday people life. More and more people ex-
change information through social networks so M-Health may exploit the network
to promote healthy behaviors and encourage cooperation among patients in groups
and communities [27].
We will discuss the m-health technologies more in detail in the following chapter,
in particular applications concerning pregnancies.
2.2 Current Uses
The worldwide development of telecommunication technology in health-care field,
expresses itself in an integrated system comprising synchronous and asynchronous
technologies such as real-time and store-and-forward ones, created to providing
optimal care to anyone, anytime and anywhere [24]. In the sequel we use E-
Health, Telemedicine and Telehealth interchangeably for simplicity, using these
terms to generally indicate the application of ICT in the health-care area.
2.2.1 Applications
Nowadays, several studies show that information and communication technology
in medical field is an increasing practice for providing medical treatments and
services [35]. In general, technology has deeply influenced many aspect of health-
care.
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The multiple applications can be classified based on particular health-care area:
1. Clinical Applications : this kind of applications includes all areas of patient
care (diagnostic, treatment and monitoring services). This area covers real-
time or store-and-forward technologies such as everyday electronic devices
like telephones and fax machines, e-mails, chat rooms, audio- and video-
conferencing [24].
2. Administrative Applications : administrative area includes billing summarize
data, connections with pharmacies for drug prescriptions and control for con-
flicts between drugs, checking medical records for mistakes or contradictions
between treatments, public health records management [24].
3. Remote Medical Instrument : these applications comprehend a whole range
of medical devices such as pressure sensors, imaging technologies and spe-
cialized robotics in context of medical areas. Typical devices of this area are
remote blood pressure cuffs, thermometers, and portable EKG units with
plug-ins for computer transmission of reports [24], order entry systems that
allow the access to medical records from a distance and smart alarms that
bring services and expert assistance in unequipped locations [35].
4. Educational Applications : educational applications refer on one side to courses
of study and updating for professionals, and on the other to patients with
educational resources and self-monitoring devices needed to help them ob-
tain behavioral changes agreed. Telementoring is an application that allows
you to learn through consultation. This is the case of professionals who shall
consult with specialist on how to diagnose and manage a specific clinical
problem in order to avoid future consultations.
Practitioners in developing countries also are able to keep informed of the
latest medical information, but in these countries there are many limitations
related to health data sharing and management. Thanks to E-Health, these
physicians can now connect with each other and other professionals [24].
Particular important are applications that concern nursing, especially in dialysis
unit. Nurses that use such kind of applications appreciate the increase of control
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in treatment and communication with their patients in the absence of supervising
doctor.
The role of telemedicine in management of chronically ill patients in their homes is
particularly important. Through telemedicine devices, patient can communicate
the doctor informations related to his/her status and immediately receive direc-
tions on what to do next. In the same way, patients can communicate with their
doctor located in hospital through home nurse and the nurse can receive feedback
useful to know how to proceed accordingly [35].
Other applications of telemedicine includes military environments and prisons too.
In military arena telemedicine can connect people who treat victims on the battle-
field with doctors in specialized areas, avoiding the physically presence of physician
who can treat another patient in hospital. Patients in prison can be treated fol-
lowing the same procedure [35].
2.2.2 Benefits
Telemedicine, as seen, offers so many benefits to all patients, physicians and com-
munity as a whole [35] because it resulted in an impressive change.
Benefits arise from known problems like unequal distribution of health-care fa-
cilities and medical staff, limited access to health-care resources for a portion of
population and continuous increase of public and private health-care costs [24].
Telemedicine and telehealth increased the quality and specialization of health-care
for patients. Patients receive assistance faster and more conveniently if a local
practitioner has the possibility to communicate immediately with a specialist.
Internet, in addition, allows to transmit many kind of medical images as well as
audio- and video-streaming.
Patients are incentivized to communicate with nursing and medical staff through
encrypted e-mails, consult web-based applications dedicated to disease manage-
ment and personal health record and self-monitoring [24] without continuous need
to travel. As such it also can eliminate the possible transmission of infectious
diseases or parasites between patients and medical staff.
E-Health could also reduce test duplication because physicians can access to pa-
tient’s most recent health information. Access to updated and complete infor-
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mations about patients can improve the quality of decision making: information
collection and storage leads to improve efficiently and safety by allowing physicians
to make better and more informed decisions [36].
Educational applications keep medical professionals up-to-date without worrying
about where they are. They receive information from on-line databases and re-
mote expert systems about nearly every condition and diagnosis [24].
E-Health sites provide medical informations about drugs and treatments to people
who should otherwise physically go to equipped facilities. This kind of services
also provides better health information for Internet surfers [35].
For groups of people like senior citizens with neurological and mobility disorders,
those who lives in high crime areas and other patients with psychiatric disorders
that live in their houses, get adequate health-care could be difficult. Technology
offers a range of practical tools that improves and makes access to health commu-
nication and services easier for these groups of people [24].
Telehealth makes a more effective allocation of health-care resources between dif-
ferent health-care facilities. Regardless of where the patient is, telehealth allows
him/her to access to medical experts, rapid diagnosis and correct treatments [24].
Some professionals work in a rural or remote environment; rural communities cre-
ate together a ”televillage” to reduce isolation and improve health-care services in
general by sharing telecommunication networks and related services [24].
Health communications are improved through telemedicine and telehealth. Com-
munications, indeed, are no longer subject to time constraints thanks to real-time
interaction. This leads to decrease patient anxiety caused by long waiting times
for a health-care provider [35].
Health organizations have now the opportunity to exceed space and time con-
straints by working outside their catchment area through telehealth technologies
[24].
Telemedicine can minimize the costs related to health-care services. It reduces
travel time and time needed to organize appointments in order to facilitate com-
munication [35]. It also offers training for family caregivers, group support through
e-mail discussion groups and direct e-mail contact with medical staff [24].
From administrative viewpoint, telemedicine decreases costs and increases effi-
ciency by simplifying patient scheduling, medical records acquisition and through
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rapid transfer of information about patients [24].
With the widespread diffusion of the Internet, health information systems can be
accessed by anyone who have a browser web and a proper identification, such as
username and password. This information system contains every personal health
information from the administrative to clinical ones and security while confiden-
tiality are guaranteed by tunneling technologies [24].
2.2.3 Drawbacks
The first and most frequently criticism moved to telemedicine is that it decreases
physical interaction between medical staff and patients. Communications are con-
veyed through technological devices in which human contact is absent. The way
telemedicine works aims to dehumanize, dissocialize and depersonalize human in-
teraction. Communication and data exchanges occur through health-care systems
between digitized people without the need of face-to-face interaction [35].
The exchange of e-mails instead of talking to each other, deprive the speech of all
non-verbal language (facial expression and gesture) leading to decrease interper-
sonal contact. Many Internet-based services actually reduce the need of contact.
From viewpoint of some nurses, the contact of touching patient coming undone.
This fact becomes particularly evident in patients with chronic pain that stay at
home that do not receive the visit of medical staff [35].
In general these technologies should not be intended as a substitute for the patient-
doctor relationship, but they should be considered as an important support tool
to it.
The adoption of telecommunication technology in health-care leads to financial
problems. Implementation cost includes hardware and software costs. Hardware
must be purchased, configured and periodically replaced. Software must be in-
stalled and periodically updated. Additional costs (in terms of time and money)
are for staff technical training and support [37].
In addition to system implementation and maintenance costs, temporary loss of
productivity may cause a decline in revenue. The adoption of telecommunication
technologies radically change work-flow for medical staff and providers that may
cause a temporary loss of productivity [37].
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Another serious drawback of telemedicine includes issues related to patient privacy.
Patients’ concern of privacy violation increases with the increase in the amount of
personal health-care data electronically stored and transmitted [37].
In M-Health standard architecture, sensitive data is exchanged through wireless
networks and this, along with public health information management, is cause of
important problems related to patient privacy [27].
Among negatively unintended consequences, there are an increase of medical errors
and an over-dependency on technology. Many medical errors are due to systems
interfaces that are often counterintuitive and the technical trainings that are not
sufficiently detailed. Continuous and massive use of technology has become ad-
dictive to organizations, that should still guarantee basic medical care without
technology, especially if a temporary disruption may be critical [37].
Cases of poor quality of many kind of medical images or patient progress reports
can compromise the quality and continuity of patient care for the reporting doctor.
Legal liabilities for some telemedical practices and difficult procedures for request-
ing refunds are disincentives to the use of telecommunication technologies. Sce-
narios in which assigning responsibilities is legally regulated differently from state
to state still exists, but evolution of technology will result in discover feasible so-
lutions to these problems [35].
The technological evolution of the last few years has forced the medical environ-
ment to adopt standards to avoid communications through all technologies. The
greater the number of technologies involved, the greater the likelihood that they
will be incompatible. These problems may have caused a considerable loss of time
[37].
2.3 Challenges
The introduction of telehealth and E-Health in professional practice is an issue
hotly debated. On one hand there is a group of professionals that embraces tech-
nological change and innovation, on the other those who want empirical validation
before adopting these practices. Most professional groups proceed cautiously [24].
From a legal viewpoint, states are adopting laws that regulate this practice and
they have potentially different legislations, so several groups, such as Federation of
24
2.3. CHALLENGES
State Medical Boards, are passing laws to allow professionals to practice telehealth
across state boundaries [24].
The problem of practitioner-patient relationship through technological tools is con-
troversial. It is necessary to have guidelines that clarify the rules for an appropriate
use of such technology and assign right responsibilities so that physicians can un-
derstand their own by studying such guidelines [24].
Refund requests for telehealth has increased significantly in the last few years.
The difficulty of receiving services reimbursement from insurance companies is a
problem to be reckoned with [35]. In order to refund telehealth services, many
states promulgated laws to support it [24].
Organizations such as World Health Organization, many branches of the U.S. gov-
ernment, American Health Information Management Association and the Ameri-
can Medical Informatics Association, consider the problem of patient privacy very
seriously. They work to provide and preserve protection of patient informations
[24].
A key aspects of telecommunications technology in health-care is training the staff.
This training, that may be expensive, time consuming and frustrating, is neces-
sary to be able to make the best use of such a technology. Telecompetence is a
term coined to indicate a set of competence that a professional must have to ap-
proach the telemedicine. Achieving this level of competence requires considerable
training and finances that not all medical realities can afford. For this reason, in
some medical settings with limited resources, telemedicine may not be a feasible
or affordable option [35].
Cooperation among M-Health applications is needed. Physicians and patients
should be able to use different services and cooperate with each other to achieve
a common result and improve performance and efficiency of devices [27].
M-Health systems play a key role in renewal process of old health-care services
that are still based on physical relationship between patient and medical staff [27].
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2.3.1 Hospital 4.0 and Internet of Things
We hear a lot about Hospital 4.0 lately. The label ”4.0” identify something im-
portant: the 4th Industrial Revolution.
The whole world is experiencing a profound change in society that conditions it in
several levels, from technological to research one. This change concerns the way
we live and the comprehension we have about different aspects of society.
In industry, the integration of different technologies such as big data, robotics and
cloud computing, leads to a complete revisitation of concept of the industry itself.
At the heart of revolution there is IoT (Internet of Things), the network which
enables these everyday objects to connect and exchange data. Internet becomes
the means that connects these objects that were previously ”dead”, without com-
putational ability. These ”things” now perceive reality and can interact with the
rest of the system that has been created. Computers will disappear because ev-
erything around us will have computational ability.
In health-care area, many electro-medical devices are now able to send parame-
ters that can feed in real time the wealth of clinical information of each patient.
From a strictly technological viewpoint, health-care facilities are the place where
thousands of byte are generated and transported by thousands of devices every
day. These data, correctly analyzed, potentially allow reactions that anticipate a
possible problem.
These systems, composed of devices equipped with sensors, continuously collect a
large amount of data related to any event that occurred. They learn and reason
from the data they sense without the need to be pre-programmed, allowing them-
selves to make decisions that lead to benefits that were previously unthinkable.
According to experts of the field, collecting as much information as possible about
the patient on the way is especially important in emergency situations where is
essential to make the right decisions. Networked devices that continuously collect
and exchange data support professionals in making more informed decisions.
Many countries still adopt old health-care model which dates back to the 20th
century, but hospitals investing in ICT has doubled in the last few years. Since
the 1980s, countries have invested in health-care technologies, but now these in-
vestments are decreasing and M-Health is becoming the way to reduce health-care
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costs [27].
M-Health brings with it a new paradigm where patients and physicians exploit the
benefits of technology which have revolutionized the world of health-care delivery
[27]. The Hospital 4.0 is the place where clinic engineering and information tech-
nology converge because are the technologies themselves that converge.
The need to have a collective network that allows the wireless exchange of informa-
tion is urgent. There are too many wires that connect devices to patients. These
wires make medical staff movement very difficult and a possible disconnection can
be a source of errors and loss of information.
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Chapter 3
ICT for Pregnancy
This chapter provides an exploration of ICT applications in the specific field of
pregnancy monitoring. We describe which systems are used to support pregnant
women achieving a healthy pregnancy, in particular in nutrition, self-management
and fetal signs monitoring fields.
We show Mobile Health systems architecture with particular attention given to
data processing techniques such as Machine Learning and Simulation Techniques.
Finally we describe Agent-Based Modeling and Simulation approach showing main
characteristics of such systems.
3.1 M-Health Technologies for Pregnancy
One of the most important area in health-care is pregnancy and maternal health.
Negative pregnancy outcomes have consequences, of course on families, but also on
health-care system. Pregnancy complications leads to an increase of costs; for ex-
ample, a C-sections is more expensive than a natural childbirth as well as hospital
costs for pre-term births and low-birth weight are almost 50% of hospitalization
costs related to neonatal department [38].
According to [38], some studies show that an hospitalization for uncomplicated de-
livery is more than 2.5 times much cheaper than hospitalization for complications
such as pre-term birth and low-birth weight infants. Negative outcomes produce
also long-term consequences such as disability and childhood neurodevelopmental
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disorders that lead to further societal costs related to special education services
and decrease of productivity by members of family caused by reduction of working
hours or job loss.
Access to prenatal care is essential to improving maternal and fetal health, and
technology gives this possibility delivering prenatal support to high-risk women
wherever they are.
3.1.1 Nutrition
Nutrition and lifestyle are particularly important during pregnancy for both mother
and baby. In this period, intervention about lifestyle are real investments for health
of current and future generations. It is important to make the future parents aware
of this.
These interventions mainly concern body weight regulation, correct nutrition, sup-
plement of folic acid and reduction in the use of tobacco [39].
Mobile Health have the potential of improving inadequate nutrition and lifestyle
providing necessary information to users. Several studies shows how this objective
is possible by using mobile phones and smartphones in order to monitoring patient
behavior during pregnancy. Mobile phones are used to collect data, keep medical
records up-to-date, promote communication between physicians and patients and
give them advices on healthy behaviors [40].
3.1.2 Self-Management
M-Health systems allow users to self-manage their own health situation. This
includes regular monitor, reporting changes in health status and changes in treat-
ments as a result of received informations from patient [40].
Self-Management relies on data acquisition and processing from which feedback
is obtained. The way data are processed and information presented depends on
specific situation in which patient is [40].
Some studies show that text and vocal messages are used like reminder to change
patient behavior and to communicate with medical staff mostly in low and middle
incoming countries [41].
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An online Web-based platform can be exploited to provide such kind of informa-
tions. Technologies like this one have to focus on prevention of Non-Communicable
Disease through providing suitable educational programs and allow an easy access
to on-line resources [39].
3.1.3 Fetal Kicking and Heart Rate Monitoring
Systems that collect data from fetal kicking and heart rate monitoring use sensors
placed on mother abdominal region through an elastic belt. Sensors are connected
to an computational unit that receives and processes data. Processed data are
typically sent to a mobile device, which is accessible to both patients and medical
staff, that displays them [41].
Collecting data about fetal movements and heartbeat provides important informa-
tions about the health status of the baby. Decrease or absence of recorded signals
could be symptomatic of a fetal loss.
Among non-invasive method that can diagnose a possible pregnancy complications
there are Doppler1 and Ultrasound echography. They are normally employed in
hospitals. This kind of examination adds important informations on health status
of mother and child when remote consultation is needed [33].
M-Health systems such as MobiHealth BAN allow women with high-risk preg-
nancy to stay at home and postpone hospitalization, through continuous monitor-
ing. This reduces costs because fetal signs, like heartbeat and blood flow in the
umbilical cord and in placenta, and physiological parameters are transmitted to
hospital [33].
3.2 Architecture of M-Health System
Concept of IoT (Internet of Things) based on mobile or stationary devices that
receive data from sensors capable of capturing aspects of the real world [42]. The
1Doppler is a clinical examination that exploits the doppler effect on ultrasound to check the
functionality of large blood vessels
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big load of captured data can be processed internally or more likely be sent to some
sort of cloud infrastructure where the computational ability is greater. This allows
a faster elaboration and thus a better quality of health-care services provided [27].
3.2.1 Sensors
Sensors can collect data in real time from environment and patients body (physio-
logical parameters). In case of emergency, remote patient monitoring allows med-
ical staff to to handle situation and intervene promptly. Processed data is used
to support physicians during decision making. Smart intelligent sensors, some of
them implanted, are developed to allow communication with personal server in
complete mobility [33].
Wearable health monitoring devices exploit PAN (Personal Area Network) or BAN
(Body Area Network) to communicate with each other.
PAN is a network for interconnecting devices centered on an individual workspace,
and BAN, on other hand, is a wireless network of wearable computing devices.
A set of wired sensors is usually connected with processing unit integrated to
user’s clothes. This system can continuously monitor the patient’s health status
even during activities even if it is unsuitable for long monitors [33].
Better results are obtained with new generation of medical monitors that integrate
intelligent sensors into wireless BAN through Bluetooth and Infrared Data Asso-
ciation.
Elaboration results should be accessed in a distributed, heterogeneous environ-
ment [42].
3.2.2 Data Processing
Data sent to computational devices have to be processed to produce significant
result. This process is usually achieved in two ways: by machine learning or
simulation techniques.
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Machine Learning Techniques
Machine Learning is a fundamental area of Artificial Intelligence. It includes
techniques and algorithms capable of automatic learning.
Machine learning techniques like neuronal networks, decision tree, SVM (Support
Vector Machine), Bayesian network, genetic algorithms, are widely use to support
decision making process. These techniques achieve usually better results than
statistical traditional methods [43].
Machine learning, in turn, includes data mining analysis that discover previously
unknown, interesting patterns from a large amount of data in order to extract
useful informations. Pattern identifies a subset of data or a model applicable to
the subset [44].
Data mining analysis aims to predict unknowns values of variable based on values
of other variables or describe patterns in data previously not human-interpretable.
These kind of techniques aims to semi-automatic or automatic analysis of data
through [44, 45]:
• Classification: Predictive activity that aims to find a model to predict value
for classification attribute based on values of other attributes.
• Clustering : Predictive activity that aims to find in a set of points, those ones
that are more similar to each other than among other subsets.
• Association rule learning : Descriptive activity that aims to search for rela-
tionships between variables.
• Regression: Predictive activity that aims to predict continuous values vari-
able based on the other assuming linear/non-linear description model be-
tween attributes.
• Anomaly detection: Predictive activity that aims to identify an abnormal
behavior that could be a data error or an interesting deviation that requires
more investigations.
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Simulation Techniques
Computer simulation is a comprehensive method for studying the evolution pro-
cess of complex systems. It attempts to reproduce the behavior of a system using a
mathematical model that predict analytical solution to a given problem. Usually
simulation concerns real world situations [46].
Many natural systems like physical and biological ones, and human systems like
economic ones, can be mathematical modeled through simulation.
This definition brings out concept of complex system that is one in which compo-
nents interact with each other: in holistic view, the whole is more than the sum
of system parts because of the interactions between the parts [47, 48].
These systems are difficult to study for severe reasons like ethical or practical ones,
evolution too slow or too fast, systems that do not exist (or do not exist yet), small
perturbation that can lead the system to extremely complex overall behavior, un-
predictable evolution [47]. Simulation helps us understand real phenomena, by
nature difficult or impossible to reproduce under controlled condition.
Simulation process begins with choice or creation of the model, and then it has to
be implemented on a computational device [46]. A model can be used as represen-
tation or abstraction of a system [47].
The implemented model receives input as a specification of the system’s state in the
form of parameters and initial conditions. Data are processed reflecting system’s
state evolution and elaboration results, which are based on modeled behavior, and
are displayed accordingly.
Algorithms and rules used to describe system behavior represent the model. Com-
puter simulation is the process of running a model through computational tools.
Simulation is particularly suitable to understanding complex systems behavior.
Several types of simulation can be defined by the granularity of their elements [49]:
• Micro-simulation: system is described as a set of smaller entities. Each en-
tity is described by the only rules that determine their behavior. Individuals
interact with each other.
• Macro-simulation: system is described as one entity. System’s components
that are described by variables and rules that define their behavior are at-
tributed to this entity. Macro level is an aggregation of micro level activities
34
3.3. AGENT-BASED MODELS
results and it used to observe emergent phenomena.
• Multi-level simulation: intermediate form in which system is described at
different time scales. Interactions occur intra- and inter-levels. This kind
of simulation is considered the better way to describing complex systems
because it allows to describe the influence that the parts have on the whole
system (upward causation) and the constraints impose to parts by the whole
(downward causation) [47].
In order to highlight progress made by simulation, Roberto Visentin at al. have
presented their Type-1 Diabetes Metabolic Simulator (T1DMS) that recently re-
ceived the Food and Drugs Administration (FDA) acceptance as a substitute for
pre-clinical animal testing of new treatment strategies [1]. Such model, imple-
mented in Simulink/MATLAB, is able to describe physical glucose-insulin dy-
namics through the simulation. In the following will be investigate in details the
Agent-Based Modeling and Simulation approach. Recent simulation systems like
[1] show the great progress in this area. The modified and updated simulator
proposed by Roberto Visentin at al., is able to describe the glucose concentration
changes in blood by simulating physical glucose-insulin dynamics through differen-
tial equations. This simulator is accepted by the Food and Drugs Administration
(FDA) as a substitute to pre-clinical trials involving animals for several insulin
treatments.
3.3 Agent-Based Models
Agent-Based Modeling (ABM) is a relatively new approach that allows to describe
a complex system as a collection of autonomous entities called ”agents” which in-
teract with each other. The interactions among agents influence their behavior
[48, 50].
An example of Agent-Based Model is shown in 3.1 Each agent has a behavior
defined by a set of rules, but they also can evolve, allowing unanticipated behav-
iors to emerge. Evolution and adaptation is achieved through providing learning
35
CHAPTER 3. ICT FOR PREGNANCY
Figure 3.1: Example of a self-management Aget-Based model [2]
techniques such as neural networks [48].
A multi agents model contains [47]:
1. Agents with their attribute and behaviors
2. Society defined by interactions among agents
3. Environment defined by topology and internal relationship
3.3.1 Characteristics of an Agent
The fundamental characteristic defining an entity as an agent is the capability
of being autonomous. Agents are active entities: their behavior is not controlled
by external directions but is autonomous. In addition, they can evolve over time
and learn by environment and other agents (pro-active behavior). Some authors
assert that capabilities like learning and changing are necessary to call such entities
”agents” [50].
As shown in [50], other characteristics of agents are explained in the follow.
Agents are uniquely identifiable individual. Agents are all different from each other
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and identifiable by their own attributes.
Their capability of acting independently in their environment makes them self-
directed. According to the model, agents can interact within a subset of a system
and over a limited situations of interest to model. An agent acts and makes decision
on the basis of other agents behavior. Information exchange takes place through
interaction among agents and environment.
Adaptive mechanisms are achieved by advanced machine learning techniques or
set of simple rules.
Agents may have goals to achieve related to their behavior. Being goals-directed
allow agents to compare their own outcomes and evaluate which behavior is the
best one to pursue in the next iterations.
An agent have a set of attribute values that defines its state at a given time. The
state can change over time. Agent’s state influences its behavior. The model’s
state is the collection of all agent’s states along with environmental one.
Static attributes (e.g. a name) do not change during simulation, the dynamic ones
do (e.g. a list of actors neighbor).
Benefits of Agent-Based Modeling
One of the main benefits provides by Agent-Based Modeling is, as already men-
tioned, the description of emergent phenomena resulting by interaction among
agents.
The relationship between agents provides a natural description of the system rather
than describing it in terms of processes. The use of differential equations is pos-
sible, but complexity of equations quickly increases as complexity of interactions
increases, until it becomes an intractable problem [48].
Agent-based model is flexible by several dimensions. Adding more agents to the
model it’s simple as well as changing level of the system’s aggregation [48].
Issues of Agent-Based Modeling
The main issues concerned agent-based modeling are two [50]: which agents can
interact with whom and what is the dynamic behind these interactions.
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Interactions between agents are usually managed by protocols which define behav-
ioral constraints.
Topology of these systems is decentralized : there is no central unit that provides
global informations to all agents or that controls agents behavior. Agents are only
aware of local informations provided by their neighbors. In this way, no agents can
interact with all other ones at any time as, instead, it happens in real systems.
This topology doesn’t allow a centralized authority to control the whole system in
order to optimize performances.
Concept of ”neighborhood” is introduced by the notion of networks where nodes
(agents) are linked (relationships) to the subset of their neighbor. Networks may
be static if the links are pre-determined and they do not change over simulation
progress, or dynamic if their link are modified according to programmed rules in
the model.
General speaking, Eric Bonabeau in [48] has defined an issue that expresses all the
other ones; he wrote ”One issue is common to all modeling techniques: a model
has to serve a purpose; a general-purpose model cannot work. The model has to be
built at the right level of description, with just the right amount of detail to serve
its purpose; this remains an art more than a science.”
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Chapter 4
Self-Management of Gestational
Diabetes Mellitus
This chapter provides a physiological description to Gestational Diabetes Mellitus
model. In particular we describe glucose metabolism and the physiology of main
organs involved in it.
We describe metabolic changes arising from pregnancy and its physiological influ-
ence on metabolism. We show what are consequences of adding placenta organ to
organism and how the changed metabolic system may leads to Gestational Dia-
betes Mellitus.
At the end of chapter we introduce the Self-Management system model used to
simulate a healthy and Type-1 diabetic patient glucose metabolism.
4.1 Metabolic System
Glucose is the main energy source for human body. Every cells of human body
needs glucose to perform its function.
Importance of glucose is related to its regulation in overall organism. Organs and
hormones work together in order to keep the delicate balance between parts of this
system. A description about metabolic system behavior is depicted in [?]
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Figure 4.1: Metabolic System [2]
4.1.1 Glucose
From the chemical viewpoint, glucose is a simple sugar with the molecular formula
C6H12O6.
Glucose is introduced with the diet and a part of it is immediately used by organ-
ism while the remainder one is stored as hepatic and muscle glycogen (molecular
formula: C6H10O5) which consists of several glucose molecules. A smaller quantity
of glycogen is stored in heart, kidney and adipose tissue [43].
Glycogenolysis is the process whereby glycogen is split into glucose. Glycogenesis
is the process in which glucose molecules are added to chains of glycogen for stor-
age.
Glycemia is typically measured in milligrams of glucose in deciliters of blood. It
tends to be stable in fasting situation and rapidly grows after eating. Two to three
hours after the meal, the blood sugar level has to return to basal values. The or-
ganism regulate glycemia in order to not exceeded healthy range (both above or
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below).
Dott. Cecilia Ragazzini, endocrinology and diabetology expert working at Os-
pedale Bufalini in Cesena, gave us an interview about normal regulation of sugar
blood and diabetes. She told us that standard fasting sugar blood level is between
60 and 110 mg/dL and postprandial peaks should not exceed 140 mg/dL.
Glycemia in pregnancy women is lower in fasting condition and a little bit greater
in postprandial condition.
Gestational Diabetes Mellitus is diagnosed due to 75g OGTT (Oral Glucose Tol-
erance Test) [51]. This test involves oral ingestion of 75g of glucose solution.
Glycemia is registered tree times: before glucose ingestion, after one and after two
hour from ingestion. Values of blood sugar have to be respectively lower than 92,
180, 153 mg/dL to avoiding possibility of GDM diagnosis.
4.1.2 Insulin and Glucagon
Glycemia is regulated mainly by two hormones: insulin and glucagon.
• Insulin: hormone responsible for glucose uptake. Insulin allows fat and
muscle cells to absorb glucose. It is secreted by pancreatic β-cells reacting
to glycemical increase. It usually measured in microUI (International Unit)
of insulin in milliliters of blood.
• Glucagon: hormone responsible for glucose release in blood flow. It allows
the liver to start glycogenolysis from which glucose is derived. It is secreted
by pancreatic α-cells reacting to glycemical decrease. It is usually expressed
in picograms in milliliters of blood.
4.1.3 Organs Physiology
Tissues involved in glucose metabolism are mainly three: intestine, which is re-
sponsible for glucose intake from meals, liver, which is responsible for glucose
storage and release in bloodstream, and muscles which are responsible for glu-
cose storage and utilization for physical activity.
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Intestine Intestinal absorption is the way in which glucose become usable by
organism. The food ingested is reduced to glucose.
The amount of glucose associated to each meal is defined as Glycemic Load (GL).
One unit of Glycemic Load approximates the effect of one gram of glucose in
bloodstream [52].
Glycemic Load definition is related to the Glycemic Index (GI) one, that describes
the metabolic response to food intake. Low-GI food is metabolized much more
slowly than the high-GI food. This one, in fact, releases glucose quickly creating
high and narrow peaks in sugar blood [52].
Liver Liver is an insulin-independent organ that stores glucose from bloodstream
in the form of hepatic glycogen and releases glucose when the blood sugar level is
too low. Glucose uptake occurs regardless of presence of insulin in blood. Process
of releasing glucose begins if there’s glucagon.
Liver releases glucose from its stored glycogen.
Muscles Muscles are insulin-dependent tissues that absorb glucose from blood-
stream. They can absorb glucose only if pancreas (β-cells) released insulin.
Muscles can also storage glucose as glycogen, but resulted glucose from glycogenol-
ysis is usable only by the muscles themselves during physical activity.
4.2 Physiology of Pregnancy
With the onset of pregnancy, many changes occur in women body. Metabolic bal-
ance is altered by organs requests concerning maternal and fetal needs.
4.2.1 Metabolic Changes in Pregnancy
From metabolic viewpoint, pregnancy can be divide in two phases [53]:
1. Anabolic phase, which lasts until about the 20th week. During this phase
occurs an increased production of steroid hormones such as estrogen and
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progesterone that brings to small increase of level of insulin sensitivity and
consequently light hyperglycemia, to ensure right glucose provision to fetus
[54, 55].
2. Catabolic phase, which lasts from about 20th to 40th week. In this period,
hormones that counteract insulin activity such as prolactin, cortisol and hPL
(human Placental Lactogen) cause insulin resistance in the liver, muscles and
neurons and consequently stronger hyperglycemia [54, 55].
During pregnancy the fasting sugar blood level diminishes with a complex and
not completely understood mechanism [55]. This decrease may be influenced by
the increase of blood volume during early gestation, increase of glucose utilization
(by both mother and fetus mostly in late pregnancy) and/or insufficient hepatic
glucose production [55]. This effect is emphasized with prolonged fasting which
means a probably decrease in level of glucose released by liver.
Experiments on fetal blood sampling seems to observe that both fetal size and
gestational age influence fetal glycemia.
Placenta During pregnancy, fetus has to feed and breathe. Placenta is a tem-
porary organ located in utero necessary to feed, protect and support fetal growth.
The umbilical cord is a conduit between the fetus and the placenta.
Process of placental-fetal glucose exchange is insulin-independent [53] and it is
achieved by concentration gradient difference through an active mechanism (en-
ergy consuming mechanism) [54].
Glucose crosses the placenta and feeds the fetus by means of the umbilical cord.
Keeping a tight grip on recommended sugar blood level is fundamental to ensure
a healthy pregnancy. Fetus exposed for a long time to an hyperglycemical envi-
ronment is much more inclined to develop macrosomia.
Nutritional Changes In pregnancy, women have to increment the amount of
calories from meals to deal with fetus needs.
According to guideline provided by Italian Ministry of Health [51], maternal body
weight should be increment by 11.5 - 16 kg (from 0.35 to 0.50 kg weekly in second
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and third trimester).
To achieve this objective is necessary to increment the diet of about 300 Kcal per
day, considering a healthy lifestyle. In case of sedentary women, the assumption
is about 150 Kcal per day [56].
Beta-cells Modification During pregnancy, insulin secretion is increased to
satisfies both maternal and fetal needs [55].
In order to minimize the impact of tissue insulin resistance, pancreatic beta-cells
produce an increased amount of insulin. The alteration of the body balance oc-
curring with pregnancy, anyway, modifies insulin secretion even before insulin re-
sistance becomes manifest [55].
The increase of beta-cells mass may contribute to producing more insulin in case
of specific pharmaceutical drugs assumption like secretogogues during pregnancy
[55].
Generally speaking, insulin resistance prepares organs to tolerate progressive beta-
cells loss of functions. In susceptible women, however, may lead to gradual loss
of glucose tolerance which may become Gestational Diabetes Mellitus or Type 2
Diabetes.
Muscle Modification The mechanism at the base of insulin resistance is not
completely known yet. Increased hormones (such as human Placental Lactogen
(hPL), progesterone, prolactin and cortisol) concentration in bloodstream , se-
creted by placenta, seems to impact on insulin resistance with the progressive
growth of fetal-placental unit [55].
In late gestation, overall insulin sensitivity decreases from 33% to 78%. In early
gestation, insulin sensitivity depends on pre-gravidic state of the mother [55].
According to [57], low estrogen levels increase insulin sensitivity while high estro-
gen levels increase insulin resistance.
Gestational Diabetes Mellitus
The balance established between mother and fetus is very delicate. In order to
maintain an healthy level of blood sugar, maternal pancreas secrets more insulin.
To prevent hyperglycemia it is important to continuously increase level of insulin,
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but when the insulin resistance rises too, the level of the sugar blood also increases
[58].
Hyperglycemia can be therefore transformed into Gestational Diabetes Mellitus
(GDM). The stress of pancreas during pregnancy is immense, so those who previ-
ously had a form of insulin resistance or lowered ability to secrete insulin are more
inclined to develop GDM [58].
Gestational Diabetes Mellitus is responsible for high fasting glycemia levels despite
hepatic glucose releasing is similar to non-diabetic women [55].
Severe Gestational-Diabetic women in late pregnancy undergo a decrease in insulin
sensibility up to 40% then the non-diabetic ones [55].
4.3 Self-Management System Model
The model presented in [2] aims to describe physiology of healthy and Type 1 dia-
betic patient. This model shows how healthy advices such as an increasing level of
physical activity and healthy nutrition can improve overall health state of patient.
System is structured in two levels: an high-level model that represent patient and
his/her interaction with the system through a tool support, and a disease model
that describes the physiological state of the patient.
A tool support like PDA (Personal Digital Assistant) makes possible the commu-
nication between models receiving data from patient such as composition of meals,
physical activity levels and vital signs from wearable devices, and sending them to
disease model for elaboration.
Simulation outlines the patient daily blood sugar flow and allows to predict him/her
health state in short and long-term period. Where the values of parameters like
levels of glycemia, hepatic and muscle glycogen, insulin and glucagon, are out of
healthy ranges, advice related to nutrition and physical activity are provided.
Starting from this model, the thesis work includes an improvement of existing
model and development of extensions related to pregnancy and Gestational Dia-
betes Mellitus.
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Chapter 5
Case Study
In this chapter we introduce case study of current Type-1 diabetes self-management
system model.
Before that, we explain the experience about the initial decision to using machine
learning techniques in order to predict future outcome of high-risk pregnancy.
We explain the changes made on the aforementioned system in order to simulate
healthy pregnancy and Gestational Diabetes Mellitus complicated one. In partic-
ular, which improvements have been made on existing model and the addition of
the placenta one to the system.
We show the changes introduced by the new organ on metabolism of the other
ones.
Results of simulation are shown at the end of chapter.
5.1 Applications of Machine Learning Techniques
Initially, the work started with the purpose of applying machine learning tech-
niques in order to analyze data related to pregnancies. Our intent was to exploit
Machine Learning techniques, such as decisional tree and Support Vector Machine
(SVM), to identify attributes that most affect pregnancy outcomes. Such at-
tributes should have been the input for the following simulation process. Another
idea has been to compare results of both elaborations for an evaluation purposes.
The main requirement to use such techniques is related to have meaningful data
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to be processed. Despite being in contact with Ospedale Bufalini, which has pro-
vided us the needed authorization to consult patient data, problems arose due to
the necessary time to collect data.
Analysis for exploration purposes on the datasets [62] did not provide any appre-
ciable result, so we decided to abandon this idea.
5.2 Improvement of Existing Model
Metabolic system presented in [2] is modeled as a Multi-Agent System in which
bloodstream represents the environment. The patient is modeled as an agent
described by age, weight and what kind of physical activity he/she performs.
Changes made to this model include: right glucose intake by meals, adjustment to
caloric consumption related to basal metabolism and regulation of liver behavior.
Nutrition The digestive system is modeled making the assumption that patient
can only ingests glucose. Thus, taking in account other nutrients (such as proteins
and lipids) effect on the body is incorrect in current model. Modeled diet has to
be only related to glucose amount.
Calories introduced with the diet have to be only those deriving from glycemic
load of the meals.
Another assumption is meant to daily calories consumption: in the modeled basal
metabolism of balanced system, calories intake must be the same amount of calo-
ries expended [59].
Digestion Another assumption is made about food time digestion: it is reason-
able to think that main meals digestion requires more time than the necessary to
snacks.
Period of digestion has been modified according to type of meal:
• if meals is one of three main daily meals such as breakfast, lunch or dinner,
total time digestion is about two and a half hours ;
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• if meals is morning or afternoon snack, total time digestion is about one
hour.
In the first third of time digestion (about 45 and 20 minutes respectively from
eating), glucose released is the 40% of total glycemic load of the meal.
The remaining glucose amount is released in following minutes (95 and 40 minutes
respectively).
Muscle-cell The amount of glucose is provided to the organism in order to fulfil
its vital functions. This quantity is only related to caloric consumption of basal
metabolism.
Caloric consumption must be relative only to carbohydrate.
Liver-cell Glucose is stored in liver as hepatic glycogen. Glycogen is obtained
from glucose losing a water molecule:
C6H12O6 −H2O −→ C6H10O5
In order to know how much glycogen is produced by glucose, it is necessary to know
the molar mass of glucose (180.16 g/mol) and the water one(18.01528 g/mol) too.
From X grams of glucose, therefore, is obtained
180.16− 18.01528
180.18
∗X
grams of glycogen (about 90% of glucose is actually transform in glycogen).
5.3 The Placenta Model
The main change to the existing model is the addition of placenta. Among its
functions, the one modeled during this work is its metabolic role in insulin regula-
tion.
Model has been extended to simulate pregnancy aspects. Aspects that have been
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modeled are the presence of placenta, increased insulin production and increased
insulin resistance.
5.3.1 Placenta-cell
Placenta secrets hormones like prolactin, cortisol and hPL (human Placental Lac-
togen) that are placed in bloodstream.
These hormones are secreted incrementally with the progression of gestation.
Placenta is also responsible for a glucose absorption from bloodstream. Thanks to
gradient concentration difference, glucose is consumed by placenta.
The following rules define placenta-cell agent behavior: Let Gint be concentration
of free internal placental glucose
1. check glycemia value in bloodstream (G)
2. if internal free glucose concentration is lower than G, glucose intake is
Ga = ka ∗ (G−Gint)
where ka is a coefficient indicating absorption speed.
5.3.2 Insulin Resistance
Muscle absorbs glucose if insulin level in bloodstream is greater than insulin basal
values [2].
Muscles detect high levels of these hormones that are responsible for a lower glucose
uptake. In order to achieved a standard glucose absorption, more insulin is needed.
The following rules define muscle-cell agent behavior: Let ks be sensitivity insulin
coefficient of muscle-cell;
1. checks hormones value in bloodstream (H)
2. checks insulin value in bloodstream (I)
3. if hormones exceed in quantity a certain threshold, ks = f(H) where f(H)
is a function that decreases as H increases.
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4. insulin perceived by muscles is
Id = ks ∗ (I − Tins)
where Tins is a insulin threshold of 7 microUI/mL (basal insulin)
5.3.3 Insulin Increment
Pancreatic β-cells produce insulin if glucose level in bloodstream is greater than a
specific threshold [2].
Pancreas reacts to insulin resistance by producing more insulin. Insulin resistance
is the result of an increased hormone concentration, so transitively pancreas be-
havior reacts to the presence of such hormones.
The following rules define pancreatic β-cell agent behavior: Let kp be coefficient
that regulates insulin production
1. checks hormones value in bloodstream (H)
2. checks glycemia value in bloodstream (G)
3. if hormones exceed in quantity a certain threshold, kp = g(H) where g(H)
is a function that increases as H increases.
4. insulin to release in bloodstream is
Ir = kp ∗ [kr ∗ (G− Tgly)]
where kr is a coefficient indicating release speed and Tins is a glycemia thresh-
old of 75 mg/dL.
5.4 Data Simulation
Model was implemented thanks to a Java Multi-Agent Simulation Library named
MASON (Multi-Agent Simulator Of Neighborhoods) [60].
51
CHAPTER 5. CASE STUDY
MASON is a simple, fast in execution and portable Multi-Agent simulation plat-
form designed to perform processes involving a large number of simulations.
5.4.1 Patient Settings
The considered patient is a sedentary woman weighing 60 kg.
She eat five times a day: she has breakfast at 7:10 a.m., morning snack at 10:00
a.m., lunch at 12:30 p.m., afternoon snack at 4:00 p.m. and dinner at 8:00 p.m. .
A sedentary patient doesn’t take any particular physical activity.
Her activities are scheduled as described in the follow:
• she wakes up at 7:00 a.m.;
• from 7:10 a.m. to 11:00 p.m. she performs a desk job;
• from 11:00 p.m. to 7:00 a.m. she sleep.
5.4.2 Simulation Settings
Simulation starts with following values:
• Glycemia ←− 75 (mg/dL): average blood sugar level.
• Hepatic Glycogen ←− 20 (g): after nocturnal fast, glycogen stored is de-
creased to allow glycogenolysis.
• Muscle Glycogen ←− 250 (g): generally after dinner, glucose is stored and
not released during night. In the morning muscles have abundant reserves.
• Insulin ←− 7 (microUI/mL): basal insulin in bloodstream.
• Glucagon ←− 50 (pg/mL): standard glucagon level in blood is between 50
and 150 pg/mL.
Caloric Consumption The patient’s sedentary lifestyle allows to burn about
0.91 Kcal/min during day and 0.64 Kcal/min during night. This consuming are
related only to carbohydrates taken.
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Meals Calories requirement has been calculated as about 2000 Kcal/day [61].
Considering the recommended amount of carbohydrates per day as about 55% of
meals, and to burn 1 gram of glucose 4 Kcal are necessary, total caloric amount
required per day is about 270 g of glucose, so daily glycemic load resulted in 270.
Calories breakdown between meals, as recommended by Endrocrinology and Di-
abelotogy division of Ospedale Bufalini in Cesena, is the one suggested from the
Gestational Diabetes Mellitus diet, as shown in 5.1.
Calorie Breakdown between Meals
Meal Caloric Subdivision (%) grams of Glucose
Breakfast 15.19 41
Morning Snack 9.26 25
Lunch 40.74 110
Afternoon Snack 4.82 13
Dinner 30 81
Table 5.1: Glycemic Load associated to each meal
53
CHAPTER 5. CASE STUDY
5.5 Simulation Result
In the following we introduce the simulation results we obtained at the end of thesis
work. The following charts describe the two-days glucose metabolism simulation.
The time is modeled as a ”step”, each step coincide to one minute, so simulations
results are related to about 1444 minutes (24 hours) or 2888 minutes (48 hours).
Every simulation starts at step 0, corresponding to 7:00 a.m., when patient wakes
up in the morning. Every meal is administrated at the same time every day. Time
and respective steps are shown in Table 5.2.
Meal Times
Meal Time Step
Breakfast 7:10 10
Morning Snack 10:00 180
Lunch 12:30 330
Afternoon Snack 16:00 540
Dinner 20:00 780
Table 5.2: Meal time scheduling
5.5.1 Improved Model Results
The following charts show the improvements obtained after the adjustment made
on simulator. These improvements are mainly about glycemic daily trend and the
liver behavior concerning glucose. metabolism.
Glucose metabolism shown in simulation results is about a healty non-pregnant
woman.
Glycemia
The Figure 5.1 shows glucose concentration in bloodstream before 5.1(a) and after
5.1(b) the thesis work.
The comparison depicts how, even if the two glicemic trends charts may look
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similar, the values they represent are profoundly different. The peaks, known as
glycemic peaks, highlight glucose intake from meals and in 5.1(a) are too low and
thin to be considered plausible, as confirmed by literature and interviews with
medical staff. On the contrary those in 5.1(b) are more plausible because they do
not exceed the 140 mg/dL threshold and their width are appropriate to a digestion
time spanning from 2 to 3 hours.
Should be noticed that afternoon snack peak in 5.1(a) is absent.
Both graphs show a slight raise in glycemia during night because of glycogenolysis.
Dott. Cecilia Ragazzini explained us that organism needs glucose to prepare itself
to daily activities. Liver releases glucose from hepatic glycogen in this span of
time.
The shown results cover 25 hours in order to highlight how the glucose metabolism
level is equal to the one depicted at the starting point, so all glucose ingested is
actually consumed during the day. Thus the metabolic system modeled is able to
keep the balance.
Hepatic Glycogen
In Figure 5.2 hepatic glycogen levels are shown. In the 5.2(a) the liver had a con-
stant glycogen income and an almost null absorption. The liver is the main organ
responsible of the glycemic regulation. After a meal intake, liver absorbs glucose
from bloodstream (until its glycogen reserve is full) in order to lower glocose level
in bloodstream, which is higher after a meal.
When the bloodstream glycemic level is too low, it releases glucose after transform-
ing its own stored glycogen. In this way, balance is guaranteed. This behavior is
clearly noticeable in 5.2(b). It is also shown how after a prolonged fasting (like
the nocturnal one) the stored glycogen level goes down to a physiological level of
20 g. The maximum amount of storable glycogen is 120 g.
5.5.2 Pregnancy Model Results
In the follow of this section are shown the results about the addition of the placenta
organ to the simulation, as well as the changes in glycemic level after the onset of
a pregnancy.
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The time interval simulated span about two days in order to show the recurring
behavior.
Glycemia
In Figure 5.3(a) is shown the glycemia of a non-pregnant woman, already described
in the precedent section.
Figure 5.3(b) depicts the glucose concentration in the bloodstream of a woman
who is carrying on a physiological pregnancy. The overall trend is very similar to
the non-pregnant woman, but fasting glucose level is on average lower than non-
pregnant one, and peaks are higher. In order to fulfill the fetus needs, the mother
endures a slight hyperglycemia. Still, glycemic level is in a safe range (60-140
mg/dL).
In Figure 5.3(c) is shown a pregnancy complicated by Gestational Diabetes Mel-
litus. In this case, the increasing of glycemia level is more prominent.
Hepatic Glycogen
In Figure 5.4(a) is shown the hepatic glycogen of a non-pregnant woman, already
described in the precedent section.
Figure 5.4(b) depicts the hepatic glycogen of a woman who is carrying on a physi-
ological pregnancy. Even though the trend is similar to the precedent chart, there
is a subtle difference in the releasing phase of glucose: despite the production of
glycogen substantially does not change from a non-pregnant woman, its release is
slower, as the literature confirms. This leads to an overall increase glycogen level.
The liver in a GDM-complicated pregnancy, as shown in Figure 5.4(c), behaves as
a physiological pregnancy one.
Muscle Glycogen
In Figure 5.5(a) is shown the muscle glycogen of a non-pregnant woman. As
described in precedent chapters, the activity level of simulated patient is always
sedentary. This leads to a minimum consumption of muscle-glycogen. The use
of muscle glycogen is a consequence of physical activity. Glucose from muscles
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cannot be reinserted in bloodstream, but only be used by the muscles themselves.
Figure 5.5(b) depicts the muscle glycogen of a woman who is carrying on a phys-
iological pregnancy. In this case, increasing levels of hormones in bloodstream
causes a muscular resistance toward insulin activity, so in order to keep the same
level of stored glycogen, is needed more insulin.
In Figure 5.5(c) is shown a pregnancy complicated by Gestational Diabetes Mel-
litus. In this case, the increased insulin resistance does not allow glucose to pen-
etrate, despite the high amount of insulin secreted by pancreas. In this way less
amount of glycogen is produced.
Insulin
In Figure 5.6(a) is shown the insulin trend of a non-pregnant woman. Insulin is
an hormone physiologically produced by pancreatic β-cells when a glycemic load
occurs, and is receipted by muscles to achieve the ability to absorb glucose from
bloodstream. As glycemia, the overall trend is substantially the same, but peaks
in pregnant woman, as shown in 5.6(b), are higher than non-pregnant ones. Mus-
cle insulin resistance causes an increment in insulin production. This simulation
seems to confirm the physiological trend of insulin release in bloodstream.
In GDM-complicated pregnancy, as shown in 5.6(c), the huge secreted insulin
amount is not enough to overcome the muscles request to be able to absorb glu-
cose. This behavior is noticeable by comparing charts in Figure 5.6 to Figure 5.5
respectively.
5.5.3 Charts Simulation Results
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(a)
(b)
Figure 5.1: Previous and actual glycemia trends
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(a)
(b)
Figure 5.2: Previous and actual hepatic glycogen trends
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(a)
(b)
(c)
Figure 5.3: Non-pregnant, pregnant, GDM-suffering woman glycemia
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(a)
(b)
(c)
Figure 5.4: Non-pregnant, pregnant, GDM-suffering woman hepatic glycogen
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(a)
(b)
(c)
Figure 5.5: Non-pregnant, pregnant, GDM-suffering woman muscle glycogen
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(a)
(b)
(c)
Figure 5.6: Non-pregnant, pregnant, GDM-suffering woman insulin level
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Conclusions
This thesis work may be divided in two different phases: a first exploratory phase
and a second one taking care of modeling and implementation.
During the first phase we performed an exploratory analysis on the problem of
maternal and fetal mortality in particular on high-risk pregnancies and how these
may be supported by technology.
Afterwards we analyzed in detail the physiology of glucose metabolism and how
it evolves during pregnancy. At the end of this phase we performed a feasibility
analysis concerning the use of machine learning techniques providing descriptive
capability. We have tried to apply these algorithms on free datasets found on the
Internet, but sadly this approach did not provide any appreciable result on such
data because of absence of meaningful data to be processed or their incompleteness
[62].
During the modeling and implementation phase we paid attention on describing
the role of placenta in glucose metabolism. In particular, we focused on the phys-
iological reactions that it induces on the body.
Before even starting the implementation phase, the existing agent-based model of
the simulator has been analyzed to understand its internal structure and behavior.
Such behavior actually simulated a correct physiological one, but from a numerical
point of view did not return probable values. A significant contribution this work
has given, it’s the improvement of the hepatic function in glucose metabolism and
the adjustment of energy intake and consumption. At the end of this particularly
time-consuming phase, a good similarity level between real-world process and sim-
ulated process is obtained.
After the improvement of existing model, we modeled metabolic changes in preg-
nancy. Such modeling was another fundamental point of this work because it
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allowed to describe the physiological phenomenon from a mathematical point of
view through a set of well-defined rules defining the involved organs behavior.
We have then implemented an improvement of the existing self-management type-
1 diabetes model and a prototype of the placenta organ that simulates the state
of pregnancy. Such analysis was based on informations about the physiological
phenomena obtained by inspecting the literature and by interviewing expert physi-
cians. Every implementation choice about the modeled phenomena has been jus-
tified by reliable sources such as the guideline of Italian Ministry of the Health or
World Health Organization.
We can state that the simulated glucose metabolism correctly models the real
physiological phenomena related to the glucose absorption and its release in the
bloodstream, even during physiological or GDM-complicated pregnancy. The in-
troduction of the placenta organ alters the system’s dynamics and it allows to
correctly describe the metabolic behavior of entities involved in the process. From
the implementation point of view, the improvement of the existing approach leads
to a much more robust and suitable model opening to novel and interesting re-
search directions, which are presented in the following paragraph.
Future Works
Among future works related to this thesis the main one is the use of such system
to elaborate a real patient data in order to predict the future outcome of his/her
conditions in a given time interval. The results may be compared to ones obtained
through traditional machine learning techniques, or even the former may be used
as input for the latter.
Before that, further improvements are required to refine the system. Among these
refinements there is, for example, one related to basal metabolism, which should
be borne by all the organs involved.
The introduction of placenta organ to the considered system lays the foundation
for a possible, better, future implementation of the simulator. At current the
state-of-the-art simulator, indeed, the implementation is almost inaccurate.
Other pathological conditions may be modeled by adding new organs and func-
tionalities.
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Changing the execution of simulation from (current) sequential to a parallel one
could provide appreciable and unexpected results that best model the physiology
of human body and could be provide a further new line of development of such
system.
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Coronado, and Kashif Saleem. Mobile-health: A review of current state in
2015. Journal of biomedical informatics, 56:265–272, 2015.
[28] NLM. Health informatics definition. Available at:
https://www.nlm.nih.gov/hsrinfo/informatics.html.
[29] American Telemedicine Association. available at:
http://www.americantelemed.org/about/about-telemedicine.
[30] Vincenzo Della Mea. What is e-health (2): The death of telemedicine? Jour-
nal of medical Internet research, 3(2), 2001.
[31] Simon Liu and Thomas Jepsen. Mobile health. IT Professional, 14(3):11–12,
2012.
[32] ICT Facts. Figures-the world in 2015. Geneva: The International Telecom-
munication Union (ITU), 2015.
[33] Robert Istepanian, Swamy Laxminarayan, and Constantinos S Pattichis. M-
health. Springer, 2014.
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